Endoscopy 2011; 43(4): 331-336
DOI: 10.1055/s-0030-1256194
Original article
 
© Georg Thieme Verlag KG Stuttgart · New York

Post-ERCP pancreatitis in 2364 ERCP procedures: is intraductal ultrasonography another risk factor?

T.  Meister1 [*] , H.  Heinzow1 [*] , A.  Heinecke2 , R.  Hoehr1 , W.  Domschke1 , D.  Domagk1
  • 1Department of Medicine B, University of Münster, Münster, Germany
  • 2Institute for Medical Informatics and Biomathematics, University of Münster, Münster, Germany
Weitere Informationen

Publikationsverlauf

submitted 21 December 2009

accepted after revision 11 October 2010

Publikationsdatum:
16. März 2011 (online)

Background and study aims: Acute pancreatitis is considered a relevant major complication following endoscopic retrograde cholangiopancreatography (ERCP); according to literature data, the incidence varies between 1.5 % and 17 %. In the present study, we aimed to identify potentially new, hitherto unknown risk factors for post-ERCP pancreatitis.

Patients and methods: A total of 2364 ERCP procedures performed in 1275 patients during the years 2004 – 2008 were included in the study. Post-ERCP pancreatitis was defined as acute abdominal pain within 48 hours following ERCP with at least 3-fold elevated levels of serum lipase and a requirement for analgesic drugs for at least 24 hours. The severity of the pancreatitis was determined using the Imrie score.

Results: In our cohort study a total of 54 different patients (2.3 %) developed post-ERCP pancreatitis. In 50 of these patients (92.6 %) the pancreatitis was mild; in 54 (7.4 %) it was severe. Patients with post-ERCP pancreatitis had highly significantly lower bilirubin levels than patients who did not have post-ERCP pancreatitis (P < 0.001). Length of hospital stay, duration of analgesics, and need for analgesic drugs were significantly higher in patients suffering from severe pancreatitis (P ≤ 0.01). In multivariate analysis, among other, already well-described risk factors we identified intraductal ultrasonography as another risk factor for post-ERCP pancreatitis, with a hazard ratio of 2.41 (P = 0.004).

Conclusions: According to our retrospective data, intraductal ultrasonography seems to be another independent risk factor for developing post-ERCP pancreatitis, which needs to be further elucidated in prospective studies.

References

  • 1 Sherman S. ERCP and endoscopic sphincterotomy-induced pancreatitis.  Am J Gastroenterol. 1994;  89 303-305
  • 2 Freeman M L, Overby C, Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success.  Gastrointest Endosc. 2004;  59 8-14
  • 3 Testoni P A. Simple measures to prevent post-ERCP pancreatitis?.  Gut. 2008;  57 1197-1198
  • 4 Fujita N, Noda Y, Kobayashi G et al. Endoscopic approach to early diagnosis of pancreatic cancer.  Pancreas. 2004;  28 279-281
  • 5 Hawes R H. Diagnostic and therapeutic uses of ERCP in pancreatic and biliary tract malignancies.  Gastrointest Endosc. 2002;  56 (6 Suppl) S201-S205
  • 6 Fukuda Y, Tsuyuguchi T, Sakai Y et al. Diagnostic utility of peroral cholangioscopy for various bile-duct lesions.  Gastrointest Endosc. 2005;  62 374-382
  • 7 Cotton P B, Lehman G, Vennes J et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus.  Gastrointest Endosc. 1991;  37 383-393
  • 8 Cheng C L, Sherman S, Watkins J L et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.  Am J Gastroenterol. 2006;  101 139-147
  • 9 Freeman M L, Nelson D B, Sherman S et al. Complications of endoscopic biliary sphincterotomy.  N Engl J Med. 1996;  335 909-918
  • 10 Pieper-Bigelow C, Strocchi A, Levitt M D. Where does serum amylase come from and where does it go?.  Gastroenterol Clin North Am. 1990;  19 793-810
  • 11 Freeman M L, DiSario J A, Nelson D B et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.  Gastrointest Endosc. 2001;  54 425-434
  • 12 Loperfido S, Angelini G, Benedetti G et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study.  Gastrointest Endosc. 1998;  48 1-10
  • 13 Williams E J, Taylor S, Fairclough P et al. Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study.  Endoscopy. 2007;  39 793-801
  • 14 Wilson C, Heath D I, Imrie C W. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems.  Br J Surg. 1990;  77 1260-1264
  • 15 Knaus W A, Draper E A, Wagner D P et al. APACHE II: a severity of disease classification system.  Crit Care Med. 1985;  13 818-829
  • 16 Faigel D, Baron T, Lewis B et al. Ensuring competence in endoscopy. Prepared by the ASGE Taskforce on Ensuring Competence in Endoscopy and American College of Gastroenterology Executive and Practice Management Committees. ASGE policy and procedures manual for gastrointestinal endoscopy: guidelines for training and practice on CD-ROM. 2005: 1-36
  • 17 Cotton P B, Garrow D A, Gallagher J et al. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years.  Gastrointest Endosc. 2009;  70 80-88
  • 18 Bailey A A, Bourke M J, Williams S J et al. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis.  Endoscopy. 2008;  40 296-301
  • 19 Vandervoort J, Soetikno R M, Tham T C et al. Risk factors for complications after performance of ERCP.  Gastrointest Endosc. 2002;  56 652-656
  • 20 Matsubayashi H, Fukutomi A, Kanemoto H et al. Risk of pancreatitis after endoscopic retrograde cholangiopancreatography and endoscopic biliary drainage.  HPB (Oxford). 2009;  11 222-228
  • 21 Domagk D, Wessling J, Reimer P et al. Endoscopic retrograde cholangiopancreatography, intraductal ultrasonography, and magnetic resonance cholangiopancreatography in bile duct strictures: a prospective comparison of imaging diagnostics with histopathological correlation.  Am J Gastroenterol. 2004;  99 1684-1689
  • 22 Tamada K, Ido K, Ueno N et al. Preoperative staging of extrahepatic bile duct cancer with intraductal ultrasonography.  Am J Gastroenterol. 1995;  90 239-246
  • 23 Tamada K, Nagai H, Yasuda Y et al. Transpapillary intraductal US prior to biliary drainage in the assessment of longitudinal spread of extrahepatic bile duct carcinoma.  Gastrointest Endosc. 2001;  53 300-307
  • 24 Vazquez-Sequeiros E, Baron T H, Clain J E et al. Evaluation of indeterminate bile duct strictures by intraductal US.  Gastrointest Endosc. 2002;  56 372-379
  • 25 Catanzaro A, Pfau P, Isenberg G A et al. Clinical utility of intraductal US for evaluation of choledocholithiasis.  Gastrointest Endosc. 2003;  57 648-652
  • 26 Menzel J, Hoepffner N, Sulkowski U et al. Polypoid tumors of the major duodenal papilla: preoperative staging with intraductal US, EUS, and CT – a prospective, histopathologically controlled study.  Gastrointest Endosc. 1999;  49 349-357
  • 27 Domagk D, Wessling J, Conrad B et al. Which imaging modalities should be used for biliary strictures of unknown aetiology?.  Gut. 2007;  56 1032
  • 28 Domagk D, Diallo R, Menzel J et al. Endosonographic and histopathological staging of extrahepatic bile duct cancer: time to leave the present TNM-classification?.  Am J Gastroenterol. 2005;  100 594-600
  • 29 Tamada K, Tomiyama T, Wada S et al. Endoscopic transpapillary bile duct biopsy with the combination of intraductal ultrasonography in the diagnosis of biliary strictures.  Gut. 2002;  50 326-331
  • 30 Domagk D, Poremba C, Dietl K H et al. Endoscopic transpapillary biopsies and intraductal ultrasonography in the diagnostics of bile duct strictures: a prospective study.  Gut. 2002;  51 240-244
  • 31 Menzel J, Poremba C, Dietl K H et al. Preoperative diagnosis of bile duct strictures – comparison of intraductal ultrasonography with conventional endosonography.  Scand J Gastroenterol. 2000;  35 77-82

1 The first two authors, T. Meister and H. Heinzow, contributed equally to this work.

D. DomagkMD 

Department of Medicine B
University of Münster

Albert-Schweitzer-Str. 33
48149 Münster
Germany

Fax: +49-251-8347576

eMail: domagkd@uni-muenster.de